Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B XNAS: LGND

Turnaround Potential

Download real time

200.86 -0.41 (-0.20%)

New 52W High in past week

132.3K

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents